[en] Human chorionic gonadotrophin (hCG) is the first specific molecule synthesized by the embryo. hcg RNA is transcribed as early as the 8-cell stage and the blastocyst produces the protein before its implantation. hCG in the uterine microenvironment binds with its cognate receptor LHCGR on the endometrial surface. This binding stimulates LIF production and inhibits IL-6 production by epithelial cells of the endometrium. These effects ensure essential help in the preparation of the endometrium for initial embryo implantation.
hCG also effects angiogenic and immunomodulatory actions as reported in many articles by our laboratories and other ones. By stimulating angiogenesis and vasculogenesis, hCG provides the placenta with an adequate maternal blood supply and optimal embryo nutrition during the invasion of the uterine endometrium.
The immunomodulatory properties of hCG are numerous and important for programming maternal immune tolerance towards the embryo. The reported effects of hCG on uterine NK, Treg and B cells, three major cell populations for the maintenance of pregnancy, demonstrate the role of this embryonic signal as a crucial immune regulator in the course of pregnancy.
Human embryo rejection for hCG-related immunological reasons has been studied in different ways, and a sufficient dose of hCG seems to be necessary to maintain maternal tolerance. Different teams have studied the addition of hCG in patients suffering from recurrent miscarriages or implantation failures. HCG could also have a beneficial or a negative impact on autoimmune diseases during pregnancy.
In this review, we will discuss the immunological impacts hCG during pregnancy and if this hormone might be used therapeutically.
Research center :
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège
PERRIER d'HAUTERIVE, Sophie ; Centre Hospitalier Universitaire de Liège - CHU > Département de gynécologie-obstétrique > Centre de procréation médicalement assistée (CPMA)
Polese, Barbara ; Université de Liège - ULiège > I3-Cellular and Molecular Immunology
Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
Nisolle, Michelle ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique
Geenen, Vincent ; Université de Liège - ULiège > Centre d'immunologie
Language :
English
Title :
Human chorionic gonadotrophin (hCG): new pleiotropic functions for an "old" hormone during pregnancy
Strott CA, Yoshimi T, Ross GT, Lipsett MB. Ovarian physiology: relationship between plasma LH and steroidogenesis by the follicle and corpus luteum; effect of HCG. J Clin Endocrinol Metab. (1969) 29:1157–67. 10.1210/jcem-29-9-11575808525
Policastro PF, Daniels-McQueen S, Carle G, Boime I. A map of the hCG beta-LH beta gene cluster. J Biol Chem. (1986) 261:5907–16. 2422163
Cole LA. New discoveries on the biology and detection of human chorionic gonadotropin. Reprod Biol Endocrinol. (2009) 7:8. 10.1186/1477-7827-7-819171054
Gridelet V, Tsampalas M, Berndt S, Hagelstein MT, Charlet-Renard C, Conrath V, et al. Evidence for cross-talk between the LH receptor and LH during implantation in mice. Reprod Fertil Dev. (2013) 25:511–22. 10.1071/RD1124123464498
Cole LA, Butler SA. Hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin free β-subunit: tumor markers and tumor promoters. J Reprod Med. (2008) 53:499–512. 18720925
Guibourdenche J, Handschuh K, Tsatsaris V, Gerbaud P, Leguy MC, Muller F, et al. Hyperglycosylated hCG is a marker of early human trophoblast invasion. J Clin Endocrinol Metab. (2010) 95:E240–4. 10.1210/jc.2010-013820660042
Hamada AL, Nakabayashi K, Sato A, Kiyoshi K, Takamatsu Y, Laoag-Fernandez JB, et al. Transfection of antisense chorionic gonadotropin β gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis. J Clin Endocrinol Metab. (2005) 90:4873–9. 10.1210/jc.2004-245815886246
Sasaki Y, Ladner DG, Cole LA. Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failures. Fertil Steril. (2008) 89:1781–6. 10.1016/j.fertnstert.2007.03.01017675003
Cole LA, Dai D, Butler SA, Leslie KK, Kohorn EI. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG. Gynecol Oncol. (2006) 102:145–50. 10.1016/j.ygyno.2005.12.04716631920
Koistinen H, Koel M, Peters M, Rinken A, Lundin K, Tapanainen JS, et al. Hyperglycosylated hCG activates LH/hCG-receptor with lower activity than hCG. Mol Cell Endocrinol. (2018) 479:103–9. 10.1016/j.mce.2018.09.00630287399
Evans J, Salamonsen LA, Menkhorst E, Dimitriadis E. Dynamic changes in hyperglycosylated human chorionic gonadotrophin throughout the first trimester of pregnancy and its role in early placentation. Hum Reprod. (2015) 30:1029–38. 10.1093/humrep/dev01625743784
Berndt S, Blacher S, Munaut C, Detilleux J, Perrier d'Hauterive S, Huhtaniemi I, et al. Hyperglycosylated human chorionic gonadotropin stimulates angiogenesis through TGF-β receptor activation. FASEB J. (2013) 27:1309–21. 10.1096/fj.12-21368623233533
Bersinger NA, Wunder DM, Nicolas M, Birkhauser MH, Porquet D, Guibourdenche J. Serum hyperglycosylated human chorionic gonadotropin to predict the gestational outcome in in vitro fertilization/intracytoplasmic sperm injection pregnancies. Fetal Diagn Ther. (2008) 24:74–8. 10.1159/00013241218504387
Butler SA, Ikram MS, Mathieu S, Iles RK. The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferation. Br J Cancer. (2000) 82:1553–6. 10.1054/bjoc.2000.1177
Cole LA, Butler S. Hyperglycosylated hCG, hCGbeta and Hyperglycosylated hCGbeta: interchangeable cancer promoters. Mol Cell Endocrinol. (2012) 349:232–8. 10.1016/j.mce.2011.10.02922101319
Cole LA, Gutierrez JM. Production of human chorionic gonadotropin during the normal menstrual cycle. J Reprod Med. (2009) 54:245–50. 19438167
Cole LA. “Background” human chorionic gonadotropin in healthy, nonpregnant women. Clin Chem. (2005) 51:1765–6. 10.1373/clinchem.2005.05650716189375
Birken S, Maydelman Y, Gawinowicz MA, Pound A, Liu Y, Hartree AS. Isolation and characterization of human pituitary chorionic gonadotropin. Endocrinology. (1996) 137:1402–11. 10.1210/endo.137.4.86259178625917
Jurisicova A, Antenos M, Kapasi K, Meriano J, Casper RF. Variability in the expression of trophectodermal markers beta-human chorionic gonadotrophin, human leukocyte antigen-G and pregnancy specific beta-1 glycoprotein by the human blastocyst. Hum Reprod. (1999) 14:1852–8. 10402404
Bonduelle ML, Dodd R, Liebaers I, Van Steirteghem A, Williamson R, Akhurst R. Chorionic gonadotrophin-β mRNA, a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes. Hum Reprod. (1988) 3:909–14. 2460490
Lopata A, Hay DL. The potential of early human embryos to form blastocysts, hatch from their zona and secrete HCG in culture. Hum Reprod. (1989) 4:87–94. 2613878
Hoshina M, Boothby M, Hussa R, Pattillo R, Camel HM, Boime I. Linkage of human chorionic gonadotrophin and placental lactogen biosynthesis to trophoblast differentiation and tumorigenesis. Placenta. (1985) 6:163–72. 2991878
Braunstein GD, Rasor J, Danzer H, Adler D, Wade ME. Serum human chorionic gonadotropin levels throughout normal pregnancy. Am J Obs Gynecol. (1976) 126:678–81. 984142
Korevaar TIM, Steegers EAP, Rijke YB De, Jaddoe VWV, Tiemeier H, Visser TJ. Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study. Eur J Epidemiol. (2015) 30:1057–66. 10.1007/s10654-015-0039-025963653
Xiong F, Li G, Sun Q, Chen P, Wang Z, Wan C, et al. Obstetric and perinatal outcomes of pregnancies according to initial maternal serum HCG concentrations after vitrified–warmed single blastocyst transfer. Reprod Biomed Online. (2019) 38:455–64. 10.1016/j.rbmo.2018.12.04030660603
Sonoda N, Katabuchi H, Tashiro H, Ohba T, Nishimura R, Minegishi T, et al. Expression of variant luteinizing hormone/chorionic gonadotropin receptors and degradation of chorionic gonadotropin in human chorionic villous macrophages. Placenta. (2005) 26:298–307. 10.1016/j.placenta.2004.07.00115823616
Katabuchi H, Ohba T. Human chorionic villous macrophages as a fetal biological shield from maternal chorionic gonadotropin. Dev Growth Differ. (2008) 50:299–306. 10.1111/j.1440-169X.2008.01030.x18445064
Yamaguchi M, Ohba T, Tashiro H, Yamada G, Katabuchi H. Human chorionic gonadotropin induces human macrophages to form intracytoplasmic vacuoles mimicking Hofbauer cells in human chorionic villi. Cells Tissues Organs. (2013) 197:127–35. 10.1159/00034280623128164
Sirikunalai P, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, et al. Associations between maternal serum free beta human chorionic gonadotropin (β-hCG) levels and adverse pregnancy outcomes. J Obstet Gynaecol. (2016) 36:178–82. 10.3109/01443615.2015.103640026368010
Craig WY, Haddow JE, Palomaki GE, Roberson M. Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS). Prenat Diagn. (2007) 27:409–14. 10.1002/pd.169917286308
Norris W, Nevers T, Sharma S, Kalkunte S. Review: HCG, preeclampsia and regulatory T cells. Placenta. (2011) 32:S182–5. 10.1016/j.placenta.2011.01.00921295851
Barjaktarovic M, Korevaar TIM, Jaddoe VWV, de Rijke YB, Peeters RP, Steegers EAP. Human chorionic gonadotropin and risk of pre-eclampsia: prospective population-based cohort study. Ultrasound Obstet Gynecol. (2019) 54:477–83 10.1002/uog.2025630834627
Barjaktarovic M, Korevaar TIM, Jaddoe VWV, de Rijke YB, Visser TJ, Peeters RP, et al. Human chorionic gonadotropin (hCG) concentrations during the late first trimester are associated with fetal growth in a fetal sex-specific manner. Eur J Epidemiol. (2017) 32:135–44. 10.1007/s10654-016-0201-327709449
Stevens FT, Katzorke N, Tempfer C, Kreimer U, Bizjak GI, Fleisch MC, et al. Gestational trophoblastic Disorders: An update in 2015. Geburtshilfe Frauenheilkd. (2015) 75:1043–50. 10.1055/s-0035-155805426556906
Wang Z, Gao Y, Zhang D, Li Y, Luo L, Xu Y. Predictive value of serum β-human chorionic gonadotropin for early pregnancy outcomes. Arch Gynecol Obstet. (2019) 265:7–10. 10.1007/s00404-019-05388-2
Paulesu L, Rao C V, Ietta F, Pietropolli A, Ticconi C, HCG and its disruption by environmental contaminants during human pregnancy. Int J Mol Sci. (2018) 19:1–11. 10.3390/ijms1903091429558393
Ghorani E, Kaur B, Fisher R, Short D, Joneborg U, W CarlsonJ, et al. Correspondence Pembrolizumab is effective for drug- trophoblastic neoplasia. Lancet. (2017) 390:2343–5. 10.1016/S0140-6736(17)32894-5
Singh P, Sarkar M, Agrawal U, Huhtaniemi I, Pal R. The transgenic expression of the β-subunit of human chorionic gonadotropin influences the growth of implanted tumor cells. Oncotarget. (2018) 9:34670–80. 10.18632/oncotarget.2615830410667
Lenhard M, Tsvilina A, Schumacher L, Kupka M, Ditsch N, Mayr D, et al. Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer. BMC Cancer. (2012) 12:2. 10.1186/1471-2407-12-222214378
Moulton HM, Yoshihara PH, Mason DH, Iversen PL, Triozzi PL. Active specific immunotherapy with a β-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: Antibody response is associated with improved survival. Clin Cancer Res. (2002) 8:2044–51. 12114402
Sachdeva R, Bhardwaj N, Huhtaniemi I, Aggrawal U, Jain SK, Zaidi R, et al. Transgenesis-Mediated reproductive dysfunction and tumorigenesis: effects of immunological neutralization. PLoS ONE. (2012) 7:e51125. 10.1371/journal.pone.005112523226476
Kvirkvelia N, Chikadze N, Makinde J, McBride JD, Porakishvili N, Hills FA, et al. Investigation of factors influencing the immunogenicity of hCG as a potential cancer vaccine. Clin Exp Immunol. (2018) 193:73–83. 10.1111/cei.1313129601077
Hirose T. Exogenous stimulation of corpus luteum formation in the rabbit: influence of extracts of human placenta, decidua, fetus, hydatid mole, and corpus luteum on the rabbit gonad. J Jpn Gynecol Soc. (1920) 16:1055.
Fang L, Yu Y, Li Y, Wang S, Zhang R, Guo Y, et al. Human chorionic gonadotropin-induced amphiregulin stimulates aromatase expression in human granulosa-lutein cells: a mechanism for estradiol production in the luteal phase. (2019) 34:2018–26. 10.1093/humrep/dez17131553790
Convissar S, Winston NJ, Fierro MA, Scoccia H, Zamah AM, Stocco C. Sp1 regulates steroidogenic genes and LHCGR expression in primary human luteinized granulosa cells. J Steroid Biochem Mol Biol. (2019) 190:183–92. 10.1016/j.jsbmb.2019.04.00330954507
Ohlsson R, Larsson E, Nilsson O, Wahlstrom T, Sundstrom P. Blastocyst implantation precedes induction of insulin-like growth factor II gene expression in human trophoblasts. Development. (1989) 106:555–9. 2598825
Perrier d'Hauterive S, Charlet-Renard C, Berndt S, Dubois M, Munaut C, Goffin F, et al. Human chorionic gonadotropin and growth factors at the embryonic–endometrial interface control leukemia inhibitory factor (LIF) and interleukin 6 (IL-6) secretion by human endometrial epithelium. Hum Reprod. (2004) 19:2633–43. 10.1093/humrep/deh450
Srisuparp S, Strakova Z, Fazleabas AT. The role of chorionic gonadotropin (CG) in blastocyst implantation. Arch Med Res. (2001) 32:627–34. 10.1016/S0188-4409(01)00330-711750740
Lobo SC, Srisuparp S, Peng X, Fazleabas AT. Uterine receptivity in the baboon: modulation by chorionic gonadotropin. Semin Reprod Med. (2001) 19:69–74. 10.1055/s-2001-1391311394206
Shi QJ, Lei ZM, Rao C V, Lin J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology. (1993) 132:1387–95. 10.1210/endo.132.3.76799817679981
North RA, Whitehead R, Larkins RG. Stimulation by human chorionic gonadotropin of prostaglandin synthesis by early human placental tissue. J Clin Endocrinol Metab. (1991) 73:60–70. 10.1210/jcem-73-1-601904453
Weedon-Fekjaer MS, Tasken K, Weedon-Fekjær MS, Taskén K. Review: spatiotemporal dynamics of hCG/cAMP signaling and regulation of placental function. Placenta. (2012) 33(Suppl.):S87–91. 10.1016/j.placenta.2011.11.00322103973
Lee CL, Chiu PC, Hautala L, Salo T, Yeung WS, Stenman UH, et al. Human chorionic gonadotropin and its free β-subunit stimulate trophoblast invasion independent of LH/hCG receptor. Mol Cell Endocrinol. (2013) 375:43–52. 10.1016/j.mce.2013.05.00923684886
Nwabuobi C, Arlier S, Schatz F, Guzeloglu-Kayisli O, Lockwood CJ, Kayisli UA. hCG: Biological functions and clinical applications. Int J Mol Sci. (2017) 18:1–15. 10.3390/ijms1810203728937611
Tsampalas M, Gridelet V, Berndt S, Foidart JM, Geenen V, d'Hauterive SP. Human chorionic gonadotropin: A hormone with immunological and angiogenic properties. J Reprod Immunol. (2010) 85:93–8. 10.1016/j.jri.2009.11.00820227765
Polese B, Gridelet V, Araklioti E, Martens H, d'Hauterive SP, Geenen V. The endocrine milieu and CD4 T-lymphocyte polarization during pregnancy. Front Endocrinol. (2014) 5:106. 10.3389/fendo.2014.0010625071722
Berndt S, Perrier d'Hauterive S, Blacher S, Pequeux C, Lorquet S, Munaut C, et al. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J. (2006) 20:2630–2. 10.1096/fj.06-5885fje17065221
Berndt S, Blacher S, Perrier d'Hauterive S, Thiry M, Tsampalas M, Cruz A, et al. Chorionic gonadotropin stimulation of angiogenesis and pericyte recruitment. J Clin Endocrinol Metab. (2009) 94:4567–74. 10.1210/jc.2009-044319837939
Herr F, Baal N, Reisinger K, Lorenz A, McKinnon T, Preissner KT, et al. HCG in the regulation of placental angiogenesis. Results of an in vitro study. Placenta. (2007) 28 (Suppl. A):S85–93. 10.1016/j.placenta.2007.02.00217382384
Bourdiec A, Bedard D, Rao C V, Akoum A. Human chorionic gonadotropin regulates endothelial cell responsiveness to interleukin 1 and amplifies the cytokine-mediated effect on cell proliferation, migration and the release of angiogenic factors. Am J Reprod Immunol. (2013) 70:127–38. 10.1111/aji.1208023351058
Reisinger K, Baal N, McKinnon T, Munstedt K, Zygmunt M. The gonadotropins: tissue-specific angiogenic factors? Mol Cell Endocrinol. (2007) 269:65–80. 10.1016/j.mce.2006.11.01517349737
Zhang Z, Huang Y, Zhang J, Liu Z, Lin Q, Wang Z. Activation of NF-κB signaling pathway during HCG-induced VEGF expression in luteal cells. Cell Biol Int. (2019) 43:344–9. 10.1002/cbin.1109030597662
Surico D, Farruggio S, Marotta P, Raina G, Mary D, Surico N, et al. Human chorionic gonadotropin protects vascular endothelial cells from oxidative stress by apoptosis inhibition, cell survival signalling activation and mitochondrial function protection. Cell Physiol Biochem. (2015) 36:2108–20. 10.1159/00043017826279419
Fournier T, Guibourdenche J, Evain-brion D. Review: hCGs: different sources of production, different glycoforms and functions. Placenta. (2015) 36:S60–S65. 10.1016/j.placenta.2015.02.00225707740
Iles RK, Delves PJ, Butler SA. Molecular and Cellular Endocrinology Does hCG or hCG LN play a role in cancer cell biology? Mol Cell Endocrinol. (2010) 329:62–70. 10.1016/j.mce.2010.07.01420654692
Lapthorn AJ1, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, et al. Crystal structure of human chorionic gonadotropin. Nature. (1994) 369:455–61. 10.1038/369455a08202136
Lehnert SA AR. Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action. Development. (1988) 104:263–73. 2474426
Mitri F, Bentov Y, Behan LA, Esfandiari N, Casper RF. GONADAL PHYSIOLOGY AND DISEASE A novel compound heterozygous mutation of the luteinizing hormone receptor -implications for fertility. Am J Hum Genet. (2014) 31:787–94. 10.1007/s10815-014-0249-5
Gallardo V, González M, Toledo F, Sobrevia L. Role of heme oxygenase 1 and human chorionic gonadotropin in pregnancy associated diseases. Elsevier B.V. (2019) 1866:165522. 10.1016/j.bbadis.2019.07.01631376481
Jahanshahi M, Saeidi M, Nikmahzar E, Babakordi F, Bahlakeh G. Effects of hCG on reduced numbers of hCG receptors in the prefrontal cortex and cerebellum of rat models of Alzheimer's disease. Biotech Histochem. (2019) 94:360–5. 10.1080/10520295.2019.157122830760053
El-Baradie SMY, Mahmoud M, Makhlouf HH. Elevated serum levels of Interleukin-15, interleukin-16, and human chorionic gonadotropin in women with preeclampsia. J Obstet Gynaecol Canada. (2009) 31:142–8. 10.1016/S1701-2163(16)34098-119327213
Nikmahzar E, Jahanshahi M, Elyasi L, Saeidi M, Babakordi F, Bahlakeh G. Human chorionic gonadotropin attenuates amyloid-β plaques induced by streptozotocin in the rat brain by affecting cytochrome c-ir neuron density. Iran J Basic Med Sci. (2019) 22:166–72. 10.22038/ijbms.2018.31412.756930834082
Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today. (1997) 18:478–82. 10.1016/S0167-5699(97)01127-49357139
Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M, Al-Shamali E. Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol. (1999) 196:122–30. 10.1006/cimm.1999.153210527564
Wang W-J, Hao C-F, Yi-Lin Yin G-J, Bao S-H, Qiu L-H, et al. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J Reprod Immunol. (2010) 84:164–70. 10.1016/j.jri.2009.12.00320106535
Sereshki N, Gharagozloo M, Ostadi V, Ghahiri A, Roghaei MA, Mehrabian F, et al. Variations in T-helper 17 and regulatory T cells during the menstrual cycle in peripheral blood of women with recurrent spontaneous abortion. Int J Fertil Steril. (2014) 8:59–66. 24695956
Ricketts RM, Jones DB. Differential effect of human chorionic gonadotrophin on lymphocyte proliferation induced by mitogens. J Reprod Immunol. (1985) 7:225–32. 10.1016/0165-0378(85)90053-14020778
Yagel S, Parhar RS, Lala PK. Trophic effects of first-trimester human trophoblasts and human chorionic gonadotropin on lymphocyte proliferation. Am J Obstet Gynecol. (1989) 160:946–53. 10.1016/0002-9378(89)90315-32785344
Prast J, Saleh L, Husslein H, Sonderegger S, Helmer H, Knöfler M. Human chorionic gonadotropin stimulates trophoblast invasion through extracellularly regulated kinase and AKT signaling. Endocrinology. (2008) 149:979–87. 10.1210/en.2007-128218063683
Palaniappan M, Menon KMJ. Human chorionic gonadotropin stimulates theca-interstitial cell proliferation and cell cycle regulatory proteins by a cAMP-dependent activation of AKT/mTORC1 signaling pathway. Mol Endocrinol. (2010) 24:1782–93. 10.1210/me.2010-004420660299
Ge YC, Li JN, Ni XT, Guo CM, Wang WS, Duan T, et al. Cross talk between cAMP and p38 MAPK pathways in the induction of leptin by hCG in human placental syncytiotrophoblasts. Reproduction. (2011) 142:369–75. 10.1530/REP-11-005321562093
Adcock EW, 3rd Teasdale T, August CS, Cox S, Meschia G, Ballaglia TC, et al. Human chorionic gonadotropin: its possible role in maternal lymphocyte suppression. Science. (1973) 181:845–7. 10.1126/science.181.4102.8454724072
Khil LY, Jun HS, Kwon H, Yoo JK, Kim S, Notkins AL, et al. Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice. Diabetologia. (2007) 50:2147–55. 10.1007/s00125-007-0769-y17676307
Schumacher A, Brachwitz N, Sohr S, Engeland K, Langwisch S, Dolaptchieva M, et al. Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy. J Immunol. (2009) 182:5488–97. 10.4049/jimmunol.080317719380797
Lea RG, Sandra O. Immunoendocrine aspects of endometrial function and implantation. Reproduction. (2007) 134:389–404. 10.1530/REP-07-016717709558
Fujiwara H. Do circulating blood cells contribute to maternal tissue remodeling and embryo-maternal cross-talk around the implantation period? Mol Hum Reprod. (2009) 15:335–43. 10.1093/molehr/gap02719346239
Schumacher A, Heinze K, Witte J, Poloski E, Linzke N, Woidacki K, et al. Human chorionic gonadotropin as a central regulator of pregnancy immune tolerance. J Immunol. (2013) 190:2650–8. 10.4049/jimmunol.120269823396945
Furcron A-E, Romero R, Mial TN, Balancio A, Panaitescu B, Hassan SS, et al. Human chorionic gonadotropin Has Anti-Inflammatory effects at the Maternal-Fetal interface and prevents Endotoxin-Induced preterm birth, but causes dystocia and fetal compromise in mice1. Biol Reprod. (2016) 94:25–8. 10.1095/biolreprod.116.139345
Zamorina SA, Litvinova LS, Yurova KA, Khaziakhmatova OG, Timganova VP, Bochkova MS, et al. The role of human chorionic gonadotropin in regulation of naïve and memory T cells activity in vitro. Int Immunopharmacol. (2018) 54:33–8. 10.1016/j.intimp.2017.10.02929100035
Schumacher A. Human chorionic gonadotropin as a pivotal endocrine immune regulator initiating and preserving fetal tolerance. Int J Mol Sci. (2017) 18:E2166. 10.3390/ijms1810216629039764
Lash GE, Robson SC, Bulmer JN. Review: functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta. (2010) 31 (Suppl.):S87–92. 10.1016/j.placenta.2009.12.02220061017
Yagel S. The developmental role of natural killer cells at the fetal-maternal interface. Am J Obs Gynecol. (2009) 201:344–50. 10.1016/j.ajog.2009.02.03019788966
Moffett A, Colucci F. Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest. (2014) 124:1872–9. 10.1172/JCI6810724789879
Bansal AS, Bora SA, Saso S, Smith JR, Johnson MR, Thum MY. Mechanism of human chorionic gonadotrophin-mediated immunomodulation in pregnancy. Expert Rev Clin Immunol. (2012) 8:747–53. 10.1586/eci.12.7723167686
Kane N, Kelly R, Saunders PTK, Critchley HOD. Proliferation of uterine natural killer cells is induced by human chorionic gonadotropin and mediated via the mannose receptor. Endocrinology. (2009) 150:2882–8. 10.1210/en.2008-130919196802
Ashkar AA, Croy BA. Functions of uterine natural killer cells are mediated by interferon gamma production during murine pregnancy. Semin Immunol. (2001) 13:235–41. 10.1006/smim.2000.031911437631
Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med. (2006) 12:1065–74. 10.1038/nm145216892062
Wan H, Versnel MA, Leijten LM, van Helden-Meeuwsen CG, Fekkes D, Leenen PJ, et al. Chorionic gonadotropin induces dendritic cells to express a tolerogenic phenotype. J Leukoc Biol. (2008) 83:894–901. 10.1189/jlb.040725818171698
Dauven D, Ehrentraut S, Langwisch S, Zenclussen AC, Schumacher A. Immune modulatory effects of human chorionic gonadotropin on dendritic cells supporting fetal survival in murine pregnancy. Front Endocrinol. (2016) 7:146. 10.3389/fendo.2016.0014627895621
Kosaka K, Fujiwara H, Tatsumi K, Yoshioka S, Sato Y, Egawa H, et al. Human chorionic gonadotropin (HCG) activates monocytes to produce interleukin-8 via a different pathway from luteinizing hormone/HCG receptor system. J Clin Endocrinol Metab. (2002) 87:5199–208. 10.1210/jc.2002-02034112414893
Wan H, Versnel MA, Cheung WY, Leenen PJ, Khan NA, Benner R, et al. Chorionic gonadotropin can enhance innate immunity by stimulating macrophage function. J Leukoc Biol. (2007) 82:926–33. 10.1189/jlb.020709217626151
Nakayama T. Human peripheral blood mononuclear cells (PBMC) in early pregnancy promote embryo invasion in vitro: HCG enhances the effects of PBMC. Hum Reprod. (2002) 17:207–212. 10.1093/humrep/17.1.20711756389
Sauss K, Ehrentraut S, Zenclussen AC, Schumacher A. The pregnancy hormone human chorionic gonadotropin differentially regulates plasmacytoid and myeloid blood dendritic cell subsets. Am J Reprod Immunol. (2018) 79:e12837. 10.1111/aji.1283729488661
Licht P, von Wolff M, Berkholz A, Wildt L. Evidence for cycle-dependent expression of full-length human chorionic gonadotropin/luteinizing hormone receptor mRNA in human endometrium and decidua. Fertil Steril. (2003) 79(Suppl. 1):718–23. 10.1016/S0015-0282(02)04822-712620482
Bourdiec A, Calvo E, Rao CV, Akoum A. Transcriptome analysis reveals new insights into the modulation of endometrial stromal cell receptive phenotype by embryo-derived signals interleukin-1 and human chorionic gonadotropin: possible involvement in early embryo implantation. PLoS ONE. (2013) 8:e64829. 10.1371/journal.pone.006482923717664
Srivastava A, Sengupta J, Kriplani A, Roy KK, Ghosh D. Profiles of cytokines secreted by isolated human endometrial cells under the influence of chorionic gonadotropin during the window of embryo implantation. Reprod Biol Endocrinol. (2013) 11:116. 10.1186/1477-7827-11-11624345207
Wang H, Liu F, Liu X, XW Z. The effect of hCG bind immunoglobulin G on maternal-interface's Th1/Th2 type cytokines and pregnancy's outcome of abortion model. Chinese J Birth Heal Hered. (2013) 21:53–5.
Bai H, Pan J, Jia X, Huang H. The inhibition effect of human chorionic gonadotropin (hCG) on mRNA expression of cytokines initiated inflammatory reaction. Chinese J Immunol. (2003) 19:193–203.
Palomino WA, Argandoña F, Azúa R, Kohen P, Devoto L. Complement C3 and decay-accelerating factor expression levels are modulated by human chorionic gonadotropin in endometrial compartments during the implantation window. Reprod Sci. (2013) 20:1103–10. 10.1177/193371911347748623427180
Schumacher A, Zenclussen AC. Human chorionic gonadotropin-mediated immune responses that facilitate embryo implantation and placentation. Front Immunol. (2019) 10:2896. 10.3389/fimmu.2019.0289631921157
Borchers AT, Naguwa SM, Keen CL, Gershwin ME. The implications of autoimmunity and pregnancy. J Autoimmun. (2010) 34:J287–99. 10.1016/j.jaut.2009.11.01520031371
Buyon JP. The effects of pregnancy on autoimmune diseases. J Leukoc Biol. (1998) 63:281–7. 10.1002/jlb.63.3.2819500514
Song XY, Zeng L, Jin W, Pilo CM, Frank ME, Wahl SM. Suppression of streptococcal cell wall-induced arthritis by human chorionic gonadotropin. Arthritis Rheum. (2000) 43:2064–72. 10.1002/1529-0131(200009)43:9<2064::AID-ANR18>3.0.CO;2-Z11014358
Van Broekhoven F, De Graaf MT, Bromberg JE, Hooijkaas H, Van Den Bent MJ, De Beukelaar JW, et al. Human chorionic gonadotropin treatment of anti-Hu-associated paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. (2010) 81:1341–4. 10.1136/jnnp.2009.17786520667866
Li N, Shigihara T, Tzioufas AG, Notkins AL, Yoon JW, Jun HS. Human chorionic gonadotropin prevents Sjögren's syndrome-like exocrinopathy in mice. Arthritis Rheum. (2007) 56:2211–5. 10.1002/art.2273717599739
Doria A, Iaccarino L, Sarzi-Puttini P, Ghirardello A, Zampieri S, Arienti S, et al. Estrogens in pregnancy and systemic lupus erythematosus. Ann N Y Acad Sci. (2006) 1069:247–56. 10.1196/annals.1351.02216855151
Doria A, Rinaldi S, Ermani M, Salaffi F, Iaccarino L, Ghirardello A, et al. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology. (2004) 43:1580–6. 10.1093/rheumatology/keh39215367746
Elbourne KB, Keisler D, McMurray RW. Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus. Lupus. (1998) 7:420–7. 10.1191/0961203986789203529736327
Hughes GC, Choubey D. Modulation of autoimmune rheumatic diseases by oestrogen and progesterone. Nat Rev Rheumatol. (2014) 10:740–51. 10.1038/nrrheum.2014.14425155581
Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med. (1978) 147:1568.83. 10.1084/jem.147.6.1568308087
Yaniv G, Twig G, Shor DBA, Furer A, Sherer Y, Mozes O, et al. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun Rev. (2015) 14:75–9. 10.1016/j.autrev.2014.10.00325449682
Maymon R, Cuckle H, Sehmi IK, Herman A, Sherman D. Maternal serum human chorionic gonadotrophin levels in systemic lupus erythematosus and antiphospholipid syndrome. Prenat Diagn. (2001) 21:143–5. 11241544
Moncayo R, Moncayo HE. A new endocrinological and immunological syndrome in SLE: Elevation of human chorionic gonadotropin and of antibodies directed against ovary and endometrium antigens. Lupus. (1995) 4:39–45. 10.1177/0961203395004001097767338
Ben-Chetrit A, Ben-Chetrit E. Systemic lupus erythematosus induced by ovulation induction treatment. Arthritis Rheum. (1994) 37:1614–7. 10.1002/art.17803711097980672
De A, Sachdeva R, Bose A, Malik M, Jayachandran N, Pal R. Human Chorionic Gonadotropin influences systemic autoimmune responses. Front Endocrinol. (2018) 9:742. 10.3389/fendo.2018.0074230574119
Shen P, Roch T, Lampropoulou V, O'Connor RA, Stervbo U, Hilgenberg E, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. (2014) 507:366–70. 10.1038/nature1297924572363
Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev Y V, et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med. (2014) 20:633–41. 10.1038/nm.355424743305
Rolle L, Memarzadeh Tehran M, Morell-García A, Raeva Y, Schumacher A, Hartig R, et al. Cutting edge: il-10-producing regulatory b cells in early human pregnancy. Am J Reprod Immunol. (2013) 70:448–53. 10.1111/aji.1215724118333
Liu J, Chen X, Hao S, Zhao H, Pang L, Wang L, et al. Human chorionic gonadotropin and IL-35 contribute to the maintenance of peripheral immune tolerance during pregnancy through mediating the generation of IL-10+ or IL-35+ Breg cells. Exp Cell Res. (2019) 383:111513. 10.1016/j.yexcr.2019.11151331362000
Muzzio D, Zygmunt M, Jensen F. The role of pregnancy-associated hormones in the development and function of regulatory B cells. Front Endocrinol. (2014) 5:39. 10.3389/fendo.2014.0003924744750
Schumacher A, Costa SD, Zenclussen AC. Endocrine factors modulating immune responses in pregnancy. Front Immunol. (2014) 5:196. 10.3389/fimmu.2014.0019624847324
Jensen F, Wallukat G, Herse F, Budner O, El-Mousleh T, Costa SD, et al. CD19 +CD5+ cells as indicators of preeclampsia. Hypertension. (2012) 59:861–8. 10.1161/HYPERTENSIONAHA.111.18827622353610
Orvieto R. Prediction of ovarian hyperstimulation syndrome: Challenging the estradiol mythos. Hum Reprod. (2003) 18:665–7. 10.1093/humrep/deg16612660254
Neulen J, Yan Z, Raczek S, Weindel K, Keck C, Weich HA, et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: Importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab. (1995) 80:1967:71. 10.1210/jcem.80.6.77756477775647
Choudhury KM. Value of serum β-hCG in pathogenesis of pre-eclampsia. J Clin Gynecol Obstet. (2012) 1:71–75. 10.4021/jcgo57w
Pabinger I, Grafenhofer H, Kaider A, Ilic A, Eichinger S, Quehenberger P, et al. Preeclampsia and fetal loss in women with a history of venous thromboembolism. Arterioscler Thromb Vasc Biol. (2001) 21:874–9. 10.1161/01.ATV.21.5.87411348890
Xia Y, Kellems RE. Is preeclampsia an autoimmune disease? Clin Immunol. (2009) 133:1–12. 10.1016/j.clim.2009.05.00419501024
Ueno A, Cho S, Cheng L, Wang J, Hou S, Nakano H, et al. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes. Diabetes. (2007) 56:1686–93. 10.2337/db06-172717360980
Muller V, Ob'edkova K, Krikheli I, Kogan I, Fedorova I, Lesik E, et al. Successful pregnancy outcome in women with recurrent IVF failure and Anti-hCG Autoimmunity: A report of three cases. Case Reports Immunol. (2016) 2016:1–5. 10.1155/2016/439153728003919
Amato F, Warnes GM, Kirby CA, Norman RJ. Infertility Caused by hCG Autoantibody. J Clin Endocrinol Metab. (2002) 87:993–7. 10.1210/jcem.87.3.833411889150
Talwar GP, Gupta JC, Nand KN, Thapa R, Mehta M. Making of vaccines against human chorionic gonadotrophin for control of fertility of women without impairment of ovulation and menstrual regularity. Reprod Immunol Open Access. (2016) 1:1–5. 10.21767/2476-1974.100004
Hearn JP, Hodges JK, Gems S. Early secretion of chorionic gonadotrophin by marmoset embryos in vivo and in vitro. J Endocrinol. (1988) 119:249–55. 10.1677/joe.0.11902493143797
Thanavala YM, Hearn JP, Hay FC, Hulme M. Characterisation of the immunological response in marmoset monkeys immunised against hCG β-subunit and its relationship with their subsequent fertility. J Reprod Immunol. (1979) 1:263–73. 10.1016/0165-0378(79)90006-8121747
Talwar GP. Making of a vaccine preventing pregnancy without impairment of ovulation and derangement of menstrual regularity and bleeding profiles. Contraception. (2013) 87:280–7. 10.1016/j.contraception.2012.08.03323040138
Simon A, Laufer N. Repeated implantation failure: Clinical approach. Fertil Steril. (2012) 97:1039–43. 10.1016/j.fertnstert.2012.03.01022464086
Li S, Wang J, Cheng Y, Zhou D, Yin T, Xu W, et al. Intrauterine administration of hCG-activated autologous human peripheral blood mononuclear cells (PBMC) promotes live birth rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure. J Reprod Immunol. (2017) 119:15–22. 10.1016/j.jri.2016.11.00627915038
Yu N, Zhang B, Xu M, Wang S, Liu R, Wu J, et al. Intrauterine administration of autologous peripheral blood mononuclear cells (PBMCs) activated by HCG improves the implantation and pregnancy rates in patients with repeated implantation failure: a prospective randomized study. Am J Reprod Immunol. (2016) 76:212–6. 10.1111/aji.1254227521928
Craciunas L, Tsampras N, Raine-Fenning N, Coomarasamy A. Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction. Cochrane Database Syst Rev. (2018) 10:CD11537. 10.1002/14651858.CD011537.pub330341915
Hong KH, Forman EJ, Werner MD, Upham KM, Gumeny CL, Winslow AD, et al. Endometrial infusion of human chorionic gonadotropin at the time of blastocyst embryo transfer does not impact clinical outcomes. Fertil Steril. (2014) 102:1591–5.e2. 10.1016/j.fertnstert.2014.08.006
Diao LH, Li GG, Zhu YC, Tu WW, Huang CY, Lian RC, et al. Human chorionic gonadotropin potentially affects pregnancy outcome in women with recurrent implantation failure by regulating the homing preference of regulatory T cells. Am J Reprod Immunol. (2017) 77:e12618. 10.1111/aji.1261828044377
Xie H, Zeng H, He D, Liu N. Effect of intrauterine perfusion of human chorionic gonadotropin before embryo transfer after two or more implantation failures: A systematic review and meta-analysis. Eur J Obstet Gynecol. (2019) 243:133–8. 10.1016/j.ejogrb.2019.10.03931704529
Gao M, Jiang X, Li B, Li L, Duan M, Sc M. Intrauterine injection of human chorionic gonadotropin before embryo transfer can improve in vitro fertilization-embryo transfer outcomes: a meta-analysis of randomized controlled trials. Fertil Steril. (2019) 112:89–97.e1. 10.1016/j.fertnstert.2019.02.02731277770
Santibañez Á, García J, Pashkova O, Colín O, Castellanos G, Sánchez AP, et al. Effect of intrauterine injection of human chorionic gonadotropin before embryo transfer on clinical pregnancy rates from in vitro fertilisation cycles: a prospective study. Reprod Biol Endocrinol. (2014) 12:9. 10.1186/1477-7827-12-924476536
Rashidi M, Aaleyasin A, Aghahosseini M, Loloi S, Kokab A, Najmi Z. Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: A randomized clinical trial in unexplained infertility. Eur J Obstet Gynecol Reprod Biol. (2013) 169:244–7. 10.1016/j.ejogrb.2013.03.00223541417
Navali N, Gassemzadeh A, Farzadi L, Abdollahi S, Nouri M, Hamdi K, et al. Intrauterine administration of hCG immediately after oocyte retrieval and the outcome of ICSI: A randomized controlled trial. Hum Reprod. (2016) 31:2520–26. 10.1093/humrep/dew23627680029
Zarei A, Parsanezhad ME, Younesi M, Alborzi S, Zolghadri J, Samsami A, et al. Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: a randomized clinical trial. Iran J Reprod Med. (2014) 12:1–6. 24799855
Hafezi M, Madani T, Arabipoor A, Zolfaghari Z, Sadeghi M, Ramezanali F. The effect of intrauterine human chorionic gonadotropin flushing on live birth rate after vitrified-warmed embryo transfer in programmed cycles: a randomized clinical trial. Arch Gynecol Obstet. (2018) 297:1571–6. 10.1007/s00404-018-4752-229626233
Wirleitner B, Schuff M, Vanderzwalmen P, Stecher A, Okhowat J, Hradecký L, et al. Intrauterine administration of human chorionic gonadotropin does not improve pregnancy and life birth rates independently of blastocyst quality: a randomised prospective study. Reprod Biol Endocrinol. (2015) 13:70. 10.1186/s12958-015-0069-1
Liu X, Ma D, Wang W, Qu Q, Zhang N, Wang X, et al. Intrauterine administration of human chorionic gonadotropin improves the live birth rates of patients with repeated implantation failure in frozen-thawed blastocyst transfer cycles by increasing the percentage of peripheral regulatory T cells. Arch Gynecol Obstet. (2019) 299:1165–72. 10.1007/s00404-019-05047-630659362
Strug MR, Su R, Young JE, Dodds WG, Shavell VI, Dyíaz-Gimeno P, et al. Intrauterine human chorionic gonadotropin infusion in oocyte donors promotes endometrial synchrony and induction of early decidual markers for stromal survival: A randomized clinical trial. Hum Reprod. (2016) 31:1552–61. 10.1093/humrep/dew08027122490
Fazleabas AT, Donnelly KM, Srinivasan S, Fortman JD, Miller JB. Modulation of the baboon (Papio anubis) uterine endometrium by chorionic gonadotrophin during the period of uterine receptivity. Proc Natl Acad Sci USA. (1999) 96:2543–8. 10.1073/pnas.96.5.254310051679
Uchida H, Maruyama T, Nishikawa-Uchida S, Miyazaki K, Masuda H, Yoshimura Y. Glycodelin in reproduction. Reprod Med Biol. (2013) 12:79–84. 10.1007/s12522-013-0144-229699134
Lee C-L, Lam KKW, Vijayan M, Koistinen H, Seppala M, Ng EHY, et al. The pleiotropic effect of Glycodelin-A in early pregnancy. Am J Reprod Immunol. (2016) 75:290–7. 10.1111/aji.1247126757357
Scholz C, Toth B, Brunnhuber R, Rampf E, Weissenbacher T, Santoso L, et al. Glycodelin a induces a tolerogenic phenotype in monocyte-derived dendritic cells in vitro. Am J Reprod Immunol. (2008) 60:501–12. 10.1111/j.1600-0897.2008.00647.x19032611
Bielfeld AP, Pour SJ, Poschmann G, Stühler K, Krüssel JS, Baston-Büst DM. A proteome approach reveals differences between fertile women and patients with repeated implantation failure on endometrial level−Does hCG render the endometrium of RIF patients? Int J Mol Sci. (2019) 20:E425. 10.3390/ijms20020425
Xiaomin Huang, Yunni Cai, Min Ding, Bo Zheng HS, Zhou J. Human chorionic gonadotropin promotes recruitment of regulatory T cells in endometrium by inducing chemokine CCL2. J Reprod Immunol. (2019) 137:102856. 10.1016/j.jri.2019.102856
Puget C, Joueidi Y, Bauville E, Laviolle B, Bendavid C, Lavoué V, et al. Serial hCG and progesterone levels to predict early pregnancy outcomes in pregnancies of uncertain viability: a prospective study. Eur J Obstet Gynecol Reprod Biol. (2018) 220:100–5. 10.1016/j.ejogrb.2017.11.02029202392
Kim YJ, Shin JH, Hur JY, Kim H, Ku SY, Suh CS. Predictive value of serum progesterone level on β-hCG check day in women with previous repeated miscarriages after in vitro fertilization. PLoS ONE. (2017) 12:e0181229. 10.1371/journal.pone.018122928708875
Brady PC, Farland LV, Racowsky C, Ginsburg E. Hyperglycosylated human chorionic gonadotropin (HCG-H) as a novel predictor of ongoing pregnancy. Fertil Steril. (2018) 110:e267–8. 10.1016/j.fertnstert.2018.07.760
Pillai RN, Konje JC, Tincello DG, Potdar N. Role of serum biomarkers in the prediction of outcome in women with threatened miscarriage: a systematic review and diagnostic accuracy meta-analysis. Hum Reprod Update. (2016) 22:228–39. 10.1093/humupd/dmv05426663220
Morley LC, Simpson N, Tang T. Human chorionic gonadotrophin (hCG) for preventing miscarriage. Cochrane Database Syst Rev. (2013) 13:CD008611. 10.1002/14651858.CD008611.pub2
Jayasena CN, Abbara A, Izzi-Engbeaya C, Comninos AN, Harvey RA, Gonzalez Maffe J, et al. Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriage. J Clin Endocrinol Metab. (2014) 99:E2652–60. 10.1210/jc.2014-195325127195
Freis A, Schlegel J, Daniel V, Jauckus J, Strowitzki T, Germeyer A. Cytokines in relation to hCG are significantly altered in asymptomatic women with miscarriage – a pilot study. Reprod Biol Endocrinol. (2018) 16:1–7. 10.1186/s12958-018-0411-530266090
Sha J, Liu F, Zhai J, Liu X, Zhang Q, Zhang B. Alteration of Th17 and Foxp3+ regulatory T cells in patients with unexplained recurrent spontaneous abortion before and after the therapy of hCG combined with immunoglobulin. Exp Ther Med. (2017) 14:1114–1118. 10.3892/etm.2017.457428810565
